TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Devendra K HiwaseChristopher N HahnElizabeth Ngoc Hoa TranRakchha ChhetriAnmol BaranwalAref A Al-KaliKirsty M SharplinDariusz LadonRachel HollinsPatricia T GreippMonika M KutynaHassan B AlkhateebTalha BadarPaul Po-Shen WangDavid Morrall RossDeepak SinghalNaranie ShanmuganathanPeter G BardyAshanka BeligaswatteDavid T YeungMark R LitzowAbhishek A MangaonkarPratyush GiriCindy H LeeAngelina YongNoemi HorvathNimit SinghalRaghu GowdaWilliam J HoganNaseema GangatMirinal S PatnaikKebede H BegnaIng Soo TiongAndrew H WeiSharad KumarAnna L BrownHamish S ScottDaniel ThomasChung Hoow KokAyalew TefferiMithun Vinod ShahPublished in: Blood (2022)